Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

February 12, 2020

Primary Completion Date

January 22, 2024

Study Completion Date

January 22, 2024

Conditions
Chronic Plaque Psoriasis
Interventions
DRUG

Topical roflumilast

Active treatment

Trial Locations (85)

10029

Arcutis Biotherapeutics Clinical Site 121, New York

11790

Arcutis Biotherapeutics Clinical Site 108, Stony Brook

14623

Arcutis Biotherapeutics Clinical Site 130, Rochester

15213

Arcutis Biotherapeutics Clinical Site 135, Pittsburgh

16635

Arcutis Biotherapeutics Clinical Site 128, Duncansville

19003

Arcutis Biotherapeutics Clinical Site 113, Exton

19008

Arcutis Biotherapeutics Clinical Site 229, Broomall

20850

Arcutis Biotherapeutics Clinical Site 125, Rockville

Arcutis Biotherapeutics Clinical Site 138, Rockville

23220

Arcutis Biotherapeutics Clinical Site 230, Richmond

27262

Arcutis Biotherapeutics Clinical Site 115, High Point

32720

Arcutis Biotherapeutics Clinical Site 237, DeLand

32771

Arcutis Biotherapeutics Clinical Site 105, Sanford

33016

Arcutis Biotherapeutics Clinical Site 202, Hialeah

33162

Arcutis Biotherapeutics Clinical Site 201, North Miami Beach

33172

Arcutis Biotherapeutics Clinical Site 209, Sweetwater

33174

Arcutis Biotherapeutics Clinical Site 131, Miami

33484

Arcutis Biotherapeutics Clinical Site 118, Delray Beach

33770

Arcutis Biotherapeutics Clinical Site 228, Largo

34470

Arcutis Biotherapeutics Clinical Site 137, Ocala

37130

Arcutis Biotherapeutics Clinical Site 221, Murfreesboro

37922

Arcutis Biotherapeutics Clinical Site 233, Knoxville

40217

Arcutis Biotherapeutics Clinical Site 217, Louisville

45324

Arcutis Biotherapeutics Clinical Site 124, Fairborn

46168

Arcutis Biotherapeutics Clinical Site 114, Plainfield

46250

Arcutis Biotherapeutics Clinical Site 214, Indianapolis

48038

Arcutis Biotherapeutics Clinical Site 116, Clinton Township

48202

Arcutis Biotherapeutics Clinical Site 212, Detroit

55432

Arcutis Biotherapeutics Clinical Site 216, Fridley

60008

Arcutis Biotherapeutics Clinical Site 102, Rolling Meadows

64506

Arcutis Biotherapeutics Clinical Site 227, Saint Joseph

70006

Arcutis Biotherapeutics Clinical Site 213, Metairie

70115

Arcutis Biotherapeutics Clinical Site 224, New Orleans

70605

Arcutis Biotherapeutics Clinical Site 211, Lake Charles

70809

Arcutis Biotherapeutics Clinical Site 111, Baton Rouge

73112

Arcutis Biotherapeutics Clinical Site 222, Oklahoma City

73118

Arcutis Biotherapeutics Clinical Site 134, Oklahoma City

75034

Arcutis Biotherapeutics Clinical Site 519, Frisco

75246

Arcutis Biotherapeutics Clinical Site 119, Dallas

76011

Arcutis Biotherapeutics Clinical Site 206, Arlington

77030

Arcutis Biotherapeutics Clinical Site 238, Houston

77845

Arcutis Biotherapeutics Clinical Site 104, College Station

78218

Arcutis Biotherapeutics Clinical Site 110, San Antonio

78229

Arcutis Biotherapeutics Clinical Site 117, San Antonio

83706

Arcutis Clinical Site 602, Boise

84088

Arcutis Biotherapeutics Clinical Site 210, West Jordan

85255

Arcutis Biotherapeutics Clinical Site 203, Scottsdale

89148

Arcutis Biotherapeutics Clinical Site 219, Las Vegas

Arcutis Biotherapeutics Clinical Site 231, Las Vegas

89509

Arcutis Biotherapeutics Clinical Site 139, Reno

89703

Arcutis Biotherapeutics Clinical Site 240, Reno

90057

Arcutis Biotherapeutics Clinical Site 508, Los Angeles

90212

Arcutis Biotherapeutics Clinical Site 239, Beverly Hills

90404

Arcutis Biotherapeutics Clinical Site 208, Santa Monica

90503

Arcutis Biotherapeutics Clinical Site 215, Santa Monica

91436

Arcutis Biotherapeutics Clinical Site 225, Encino

Arcutis Biotherapeutics Clinical Site 223, Boynton Beach

92024

Arcutis Biotherapeutics Clinical Site 127, Encinitas

92123

Arcutis Biotherapeutics Clinical Site 123, San Diego

Arcutis Biotherapeutics Clinical Site 220, San Diego

92688

Arcutis Biotherapeutics Clinical Site 511, Rancho Santa Margarita

92697

Arcutis Biotherapeutics Clinical Site 120, Irvine

92708

Arcutis Biotherapeutics Clinical Site 509, Fountain Valley

94132

Arcutis Biotherapeutics Clinical Site 136, San Francisco

94538

Arcutis Biotherapeutics Clinical Site 112, Fremont

02135

Arcutis Biotherapeutics Clinical Site 101, Brighton

03801

Arcutis Biotherapeutics Clinical Site 236, Portsmouth

08520

Arcutis Biotherapeutics Clinical Site 129, East Windsor

T1Y 0B4

Arcutis Biotherapeutics Clinical Site 132, Calgary

V3R 6A7

Arcutis Biotherapeutics Clinical Site 207, Surrey

V3V0C6

Arcutis Biotherapeutics Clinical Site 226, Surrey

R3M 3Z4

Arcutis Biotherapeutics Clinical Site 232, Winnepeg

E3B 1G9

Arcutis Biotherapeutics Clinical Site 234, Fredericton

L1S 7K8

Arcutis Biotherapeutics Clinical Site 205, Ajax

L4M 7G1

Arcutis Biotherapeutics Clinical Site 218, Barrie

N6H 5L5

Arcutis Biotherapeutics Clinical Site 103, London

L5H 1G9

Arcutis Biotherapeutics Clinical Site 133, Mississauga

K2C 3N2

Arcutis Biotherapeutics Clinical Site 140, Ottawa

K9J 5K2

Arcutis Biotherapeutics Clinical Site 109, Peterborough

M4W 2N2

Arcutis Biotherapeutics Clinical Site 235, Toronto

N2J 1C4

Arcutis Biotherapeutics Clinical Site 106, Waterloo

N8W 1E6

Arcutis Biotherapeutics Clinical Site 204, Windsor

H3Z 2S6

Arcutis Biotherapeutics Clinical Site 107, Montreal

G1V4X7

Arcutis Biotherapeutics Clinical Site 126, Québec

Unknown

Arcutis Clinical Site 601, Santo Domingo

Sponsors
All Listed Sponsors
lead

Arcutis Biotherapeutics, Inc.

INDUSTRY

NCT04286607 - Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis | Biotech Hunter | Biotech Hunter